Sveriges mest populära poddar
Hematologic Oncology Update
Hälsa och motionMedicin

Oncology Today with Dr Neil Love: Emerging Role of CELMoDs (Cereblon E3 Ligase Modulators) and Other Novel Approaches to Targeting Protein Degradation Pathways in Multiple Myeloma

39 min•28 september 2023

Dr Paul G Richardson from Dana-Farber Cancer Institute in Boston discusses the emerging role of CELMoDs and other novel approaches to targeting protein degradation pathways in the treatment of multiple myeloma.

Fler avsnitt av Hematologic Oncology Update

Visa alla avsnitt av Hematologic Oncology Update
Immune Thrombocytopenia — Microlearning Activity 4 with Dr Hanny Al-Samkari: ASH 2025 Review
•25 min
CELMoDs for Multiple Myeloma — Microlearning Activity 1 with Dr Paul G Richardson
•24 min
Immune Thrombocytopenia — Microlearning Activity 3 with Dr Hanny Al-Samkari: ASH 2025 Review
•29 min
CD19 x CD3 BiTEs for Acute Lymphoblastic Leukemia — An Interview with Dr Bijal Shah
•1 tim 3 min
Chronic Lymphocytic Leukemia — An Interview with Prof Constantine Tam on Key Presentations from the 2025 ASH Annual Meeting
•47 min
Immune Thrombocytopenia — Microlearning Activity 2 with Dr Hanny Al-Samkari: ASH 2025 Review
•19 min
Immune Thrombocytopenia — Microlearning Activity 1 with Dr Hanny Al-Samkari: ASH 2025 Review
•24 min
Multiple Myeloma: Inside the Issue of Cereblon E3 Ligase Modulators
•58 min
Relapsed/Refractory Multiple Myeloma — Microlearning Activity 2 with Dr Sagar Lonial: ASH 2025 Review
•17 min
Immune Thrombocytopenia — ASH 2025 Review
•1 tim 30 min

Hematologic Oncology Update med Dr. Neil Love finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.